Article Details
Retrieved on: 2021-02-12 15:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... may be partially or fully resistant to certain SARS-CoV-2 monoclonal antibodies currently authorized for use as therapeutics in the United States.
Article found on: www.nih.gov
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here